Prognostic value of preoperative serum ferritin in hepatocellular carcinoma patients undergoing transarterial chemoembolization

Fan Mi(Mianyang Central Hospital), Xiaobo Du(Mianyang Central Hospital), Bangxian Tan(Affiliated Hospital of North Sichuan Medical College), Feng Gao(Mianyang Central Hospital), Tingting Niu(Mianyang Central Hospital), Binwei Lin(Mianyang Central Hospital)
Molecular and Clinical Oncology
January 24, 2024
10.3892/mco.2024.2720
Cited by 3

Related Papers

Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer
|JNCI Journal of the National Cancer Institute|2022|267
First demonstration of the FLASH effect with ultrahigh dose rate high-energy X-rays
|Radiotherapy and Oncology|2021|144
Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial
|Radiotherapy and Oncology|2017|104
Research progress on the mechanism of radiation enteritis
|Frontiers in Oncology|2022|42
Concurrent three-dimensional conformal radiotherapy and chemotherapy for postoperative recurrence of mediastinal lymph node metastases in patients with esophageal squamous cell carcinoma: a phase 2 single-institution study
|Radiation Oncology|2014|41